Viridian Therapeutics Eulerpool Ziņas

Viridian Therapeutics Akciju Ziņas

Viridian Therapeutics tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Viridian Therapeutics ziņas mēs apkopojam šeit.

• 5. jūnijs ·

  Yahoo
  Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 30. maijs ·

  Yahoo
  Viridian Therapeutics to Participate in Upcoming June Investor Conferences
• 20. maijs ·

  Yahoo
  Viridian Therapeutics Announces Positive Long-Term Durability Data from the Veligrotug Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease (TED)
• 6. maijs ·

  Yahoo
  Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2025 Financial Results
• 2. maijs ·

  Yahoo
  Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 7. aprīlis ·

  Yahoo
  Viridian Therapeutics Appoints Jeff Ajer to its Board of Directors
• 2. marts ·

  SeekingAlpha
  Viridian Therapeutics: Positive Data In TED, Strong Cash Position, 1.5-Year Window
• 8. janvāris ·

  Yahoo
  Viridian Therapeutics Highlights 2025 Corporate Priorities Following Positive Phase 3 Topline Data in Thyroid Eye Disease
• 19. decembris ·

  SeekingAlpha
  Viridian: Positive Chronic TED Data Likely To Lead To BLA Filing In Second Half Of 2025 (Rating Upgrade)
• 18. decembris ·

  SeekingAlpha
  Viridian Therapeutics: Veligrotug De-Risked In TED With Hints Of Differentiation